Cargando…
The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)
For over 40 years, the National Institute of Neurological Disorders and Stroke/National Institutes of Health-funded Anticonvulsant Screening Program has provided a preclinical screening service for participants world-wide that helped identify/characterize new antiseizure compounds, a number of which...
Autores principales: | Kehne, John H., Klein, Brian D., Raeissi, Shamsi, Sharma, Shalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504134/ https://www.ncbi.nlm.nih.gov/pubmed/28462454 http://dx.doi.org/10.1007/s11064-017-2275-z |
Ejemplares similares
-
Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program
por: Pernici, Chelsea D., et al.
Publicado: (2021) -
A User's Guide to the NINDS rt-PA Stroke Trial Database
por: Dachs, Robert J, et al.
Publicado: (2008) -
Risk of selection bias assessment in the NINDS rt-PA stroke study
por: Garg, Ravi, et al.
Publicado: (2022) -
NINDS Strategies for Enhancing the Diversity of Neuroscience Researchers
por: Jones-London, Michelle
Publicado: (2020) -
Preclinical common data elements (CDEs) for epilepsy: A joint ILAE/AES and NINDS translational initiative
por: Scharfman, Helen E., et al.
Publicado: (2018)